Biogen Inc.BIIBNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +2.87% | +6.13% | +7.33% | -0.45% | -7.15% |
| Gross Profit Growth | +5.84% | +3.39% | +12.60% | -13.62% | -4.71% |
| EBITDA Growth | +15.05% | +10.92% | +14.61% | +15.75% | -56.82% |
| Operating Income Growth | -0.66% | +6.11% | +60.46% | +6.34% | -111.20% |
| Net Income Growth | +6.81% | -38.87% | +8.77% | +20.08% | -118.15% |
| EPS Growth | +6.40% | -39.11% | +8.48% | +19.10% | -118.03% |
| EPS Diluted Growth | +7.02% | -39.26% | +8.75% | +19.17% | -118.03% |
| Weighted Average Shares Growth | +0.55% | +0.48% | +0.21% | +0.62% | +0.69% |
| Weighted Average Shares Diluted Growth | +0.27% | +0.00% | +0.00% | +0.82% | +0.41% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +5987.20% | -53.13% | -74.29% | +36.01% | -32.71% |
| Free Cash Flow Growth | +0.00% | -50.91% | -75.26% | +52.22% | -19.97% |
| Receivables Growth | -11.01% | -0.16% | +0.28% | -6.95% | -0.10% |
| Inventory Growth | -2.65% | -9.65% | -9.25% | -10.52% | -11.88% |
| Asset Growth | +4.49% | +5.52% | +5.69% | +3.16% | +4.96% |
| Book Value per Share Growth | +12.33% | +11.07% | +10.75% | +10.62% | +8.47% |
| Debt Growth | -9.65% | -4.68% | -0.97% | -0.91% | +4.79% |
| R&D Expense Growth | +5.56% | +4.24% | -10.54% | -45.08% | -25.49% |
| SG&A Expenses Growth | +11.61% | -0.64% | +5.63% | +3.10% | +0.63% |